Strata Critical Medical (SRTA) Depreciation and Depletion (2021 - 2026)

Strata Critical Medical (SRTA) has 6 years of Depreciation and Depletion data on file, last reported at $1.6 million in Q1 2026.

• Quarterly Depreciation and Depletion rose 92.89% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.3 million (up 87.34% YoY) and the FY2025 annual result came in at $4.3 million, up 114.8% from the prior year.
• Depreciation and Depletion grew to $1.6 million in Q1 2026 per SRTA's latest filing, from $1.5 million in the prior quarter.
• Across five years, Depreciation and Depletion topped out at $1.6 million in Q1 2026 and bottomed at $148000.0 in Q1 2022.
• The 5-year median for Depreciation and Depletion is $663000.0 (2024), against an average of $737769.2.
• The widest annual swing landed in 2024, when Depreciation and Depletion soared 184.25%; it then surged 55.43% in 2025.
• Tracing SRTA's Depreciation and Depletion over 5 years: stood at $148000.0 in 2022, then soared by 84.46% to $273000.0 in 2023, then soared by 184.25% to $776000.0 in 2024, then soared by 97.42% to $1.5 million in 2025, then advanced by 2.74% to $1.6 million in 2026.
• Per Business Quant, the three latest SRTA Depreciation and Depletion figures stand at $1.6 million (Q1 2026), $1.5 million (Q4 2025), and $1.1 million (Q3 2025).

Peer Comparison